Showing 1 - 2 results of 2 for search 'Hedva Lerman Shacham', query time: 0.02s Refine Results
  1. 1
    DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers.

    DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers. by Moran Artzi, Einat Even-Sapir, Hedva Lerman Shacham, Avner Thaler, Avi Orr Urterger, Susan Bressman, Karen Marder, Talma Hendler, Nir Giladi, Dafna Ben Bashat, Anat Mirelman

    Published 2017-01-01
    Get full text
    Article
  2. 2
    Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease

    Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease by Dafna Ben Bashat, Avner Thaler, Hedva Lerman Shacham, Einat Even-Sapir, Matthew Hutchison, Karleyton C. Evans, Avi Orr-Urterger, Jesse M. Cedarbaum, Amgad Droby, Nir Giladi, Anat Mirelman, Moran Artzi

    Published 2022-10-01
    Get full text
    Article

Search Tools: